Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 45,853 | |
Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 17,640 | -- | -- | |
Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 11,782 | -- | -- | |
Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 50,000 | -- | -- | |
Sep 14, 2020 | SVP/GM, VIT | Form 3 | Initial Statement of Beneficial Ownership of Securities | 12,000 | -- | -- | |
Aug 11, 2020 | EVP and CFO | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,013 | $9.38 | 60,273 | |
Jul 31, 2020 | Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 40,000 | $8.26 | 343,319 | |
Jul 27, 2020 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 259 | $8.80 | 23,724 | |
Jul 27, 2020 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,799 | $8.80 | 303,319 | |
Jul 27, 2020 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 292 | $8.80 | 59,260 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.